<?xml version="1.0" encoding="UTF-8"?>
<p id="Par97">Given the high morbidity and mortality as well as the lack of vaccines and of specific antiviral therapy for most of these infections, preventive measures remain the best approach to reducing the spread of viral infections in myeloma patients and in subjects with HSCT. It is also important to raise awareness among patients and healthcare professionals about the impact of these viruses on immunocompromised patients [
 <xref ref-type="bibr" rid="CR29">29</xref>].
</p>
